Facts about Nycomed Canada
Learn more about Nycomed Canada by reading our fact sheet.
Latest News
26.04.10
Nycomed and Merck & Co., Inc., announce commercialization agreements for Daxas® in Europe and Canada
 Zurich, Switzerland, and Whitehouse Station, N.J, April 26, 2010 – Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced ......
13.04.10
NYCOMED CANADA RECOGNIZED BY ‘BEST WORKPLACES IN CANADA’ LIST 2010
Great Place to Work® Institute Canada Ranks Nycomed as top pharmaceutical employer ...
09.09.09
Four studies published in The Lancet show roflumilast (Daxas), a new oral approach to COPD, improves lung function and reduces exacerbations
Lancet Canadian Press Release ...
Media
Information available to the media and public in this section includes, Current Releases and Archived Releases, as well as a Nycomed Canada Fact Sheet. 

Members of the media who wish to contact Nycomed for information, may do so by calling (905) 469-9333 or toll free at 1 (888) 367-3331, or by email at canadian.communications@nycomed.com.


Corporate Media
Find Nycomed’s corporate press releases, publications, financial reports and upcoming events.


Disclaimer